Gümüşoğlu Alpen Yahya, Kabuli Hamit Ahmet, Değerli Mahmut Said, Atar Burak, Köneş Osman, Kocataş Ali, Bingül Nilsu Damla, Dolay Kemal
Department of General Surgery, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
Department of General Surgery, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey.
Surg Endosc. 2024 Dec;38(12):7187-7194. doi: 10.1007/s00464-024-11305-9. Epub 2024 Oct 4.
Intrabiliary rupture (IBR) is one of the most common complications of hepatic hydatid cysts (HHC),and the surgical treatment of major intrabiliary rupture (MIBR) leads to serious morbidity and mortality. This study aimed to evaluate the efficacy of endoscopic definitive treatment of these patients.
This study included 38 patients who underwent ERCP for MIBR between 2004 and 2022. Endoscopic sphincterotomy (ES) was performed, followed by evacuation of hydatid contents from the main bile ducts and cyst cavity. A nasobiliary drainage (NBD) catheter was placed inside the cyst cavity in 15 patients, while biliary stenting (BS) was performed in 23 patients. Demographic data, cyst characteristics, hospital stay, complications, treatment success, and recurrence were analyzed.
The mean age of patients was 46.5 years, with 12 female and 26 male. All patients had WHO-type-3B hydatid cysts with an average diameter of 7.9 cm. NBD was continued for definitive purposes in 13 of the 15 patients who underwent NBD, and full cure was achieved in 13 patients. Among the 23 patients who underwent biliary stenting (BS), 16 (69.5%) required a second ERCP due to jaundice or cholangitis, and 6 (26%) underwent percutaneous drainage due to hydatid cavity infection. The average length of hospital stay was 16.13 days in the BS group, while it was 8.3 days in the NBD group.The average follow-up period was 23 months. All patients achieved complete recovery.
The endoscopic approach is an effective and safe method for the treatment of MIBR, and can be considered as a definitive treatment option in centers with adequate resources and experienced endoscopists.
胆管内破裂(IBR)是肝包虫囊肿(HHC)最常见的并发症之一,而主要胆管内破裂(MIBR)的手术治疗会导致严重的发病率和死亡率。本研究旨在评估对这些患者进行内镜确定性治疗的疗效。
本研究纳入了2004年至2022年间因MIBR接受内镜逆行胰胆管造影(ERCP)的38例患者。进行了内镜括约肌切开术(ES),随后从主胆管和囊肿腔中清除包虫内容物。15例患者在囊肿腔内放置了鼻胆管引流(NBD)导管,23例患者进行了胆管支架置入(BS)。分析了人口统计学数据、囊肿特征、住院时间、并发症、治疗成功率和复发情况。
患者的平均年龄为46.5岁,其中女性12例,男性26例。所有患者均为WHO 3B型包虫囊肿,平均直径为7.9 cm。在接受NBD的15例患者中,有13例为了确定性目的继续进行NBD,13例患者实现了完全治愈。在接受胆管支架置入(BS)的23例患者中,16例(69.5%)因黄疸或胆管炎需要进行第二次ERCP,6例(26%)因包虫腔感染接受了经皮引流。BS组的平均住院时间为16.13天,而NBD组为8.3天。平均随访期为23个月。所有患者均实现了完全康复。
内镜治疗方法是治疗MIBR的一种有效且安全的方法,在有足够资源和经验丰富的内镜医师的中心可被视为一种确定性治疗选择。